United States · Retail pharmacy · Brand-name

Kroger Pharmacy review

Fills the Medicare GLP-1 Bridge at $50/month for Wegovy, Zepbound KwikPen or Foundayo — the cheapest brand-name route here, if you are on Medicare Part D and meet the criteria.

Reviewed 2026-08-188/13 checklist items publishedProvider site ↗

Overview

Kroger’s pharmacy pages carry a striking number. Its GLP-1 Bridge Program states: “If you qualify, you may be able to receive medications like Wegovy (tablets or injectable), Zepbound Kwikpen, or Foundayo for $50/month.” That is well below every other brand-name route reviewed here, and below most compounded ones too.

The “if you qualify” is now answerable, and the answer is not Kroger’s to give. This is the Medicare GLP-1 Bridge, a federal programme that began on 1 July 2026 — the drug list matches exactly, as does the price. Kroger is a pharmacy filling it, not a retailer discounting anything, and the same $50 is available at any participating pharmacy.

Which means the qualifying criteria are published, just not by Kroger. You need Medicare Part D coverage, you must not already be able to get a GLP-1 through your plan, you must not have type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease, and you need a qualifying BMI. Our guide at /guides/medicare-glp1-bridge sets all four out in full.

We still give this entry no entry price, because $50 is not a Kroger price and ranking it as one would suggest that shopping here gets you something shopping elsewhere does not. It does not. What Kroger offers is a pharmacy counter that fills the programme, alongside a stock list that includes all three of the newer oral options.

Medications and supply

Brand-name only, through Kroger Pharmacy. Notably it carries all three of the newer oral options alongside the injections, including Foundayo. Nothing compounded is involved.

Wegovy (semaglutide) tablets and injection
Zepbound Kwikpen (tirzepatide)
Foundayo (orforglipron)

How the service works

Consultation: None. Kroger dispenses against a prescription from your own provider.
Eligibility: Set by Medicare, not by Kroger: Part D coverage, no existing GLP-1 route through your plan, none of type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease, and a qualifying BMI — 35+, or 30+ with certain heart failure, hard-to-control blood pressure or stage 3a+ chronic kidney disease, or 27+ with prediabetes or prior heart attack, stroke or peripheral arterial disease.
Provider involvement: Your own prescriber. Kroger dispenses.
Lab requirements: Not stated in the sources we checked.
Pharmacy fulfilment: Kroger Pharmacy, including The Little Clinic locations.
Shipping: Not stated in the sources we checked.
Support services: In-store pharmacists.

What it costs

Published prices for Kroger Pharmacy
Item	Published price	Notes
Medicare GLP-1 Bridge — Wegovy, Zepbound KwikPen or Foundayo	$50 / month	A federal programme Kroger fills, not a Kroger discount. Medicare Part D only, with four eligibility tests

Membership fee: None published.
Medication fee: The Bridge Program price is the medication.
Insurance: The Bridge Program sits alongside Kroger’s wider prescription insurance and savings pages, which suggests it is aimed at coverage gaps rather than at general cash buyers.
HSA / FSA: Not stated in the sources we checked.
Cancellation: Not stated in the sources we checked.
Refunds: Not stated in the sources we checked.

Pros

Fills the Medicare GLP-1 Bridge at $50 a month, the lowest brand-name price we have found anywhere for those eligible.
Carries Foundayo and oral Wegovy alongside the injectables — one of the few retail routes listing all the newer oral options.
Brand-name throughout, with no compounding or litigation exposure.
No membership gate, unlike Costco and Sam’s Club.

Cons

The $50 is a Medicare programme, so it is unavailable to anyone not on Part D — which is most people under 65.
No unconditional cash price is published, which is why this entry carries no entry price at all.
No consultation offered — you need a prescriber already.
kroger.com blocked every retrieval route we tried, including the archive.

Who it may suit

A Medicare Part D beneficiary who meets the Bridge criteria and has a Kroger nearby. Check your eligibility against the federal rules first — the $50 follows the programme rather than the pharmacy, so any participating pharmacy will do, and Kroger’s advantage is stocking all three oral options.

Limitations

kroger.com requires premium access on our retrieval provider and has no usable archive snapshot, so the quoted text comes from the search index rather than the page.
We could not verify Kroger’s own cash prices for anyone outside the Medicare programme, so this entry is excluded from price rankings.
How long the Bridge runs, and what a beneficiary pays when it ends, is not stated in the material we could reach.

Questions

Is Kroger really $50 a month?

For Medicare Part D beneficiaries who qualify, yes — but it is not a Kroger price. Kroger is filling the Medicare GLP-1 Bridge, a federal programme that began on 1 July 2026 covering Wegovy, the Zepbound KwikPen and Foundayo at $50 a month. Any participating pharmacy charges the same.

Why is Kroger not in your cheapest list?

Because $50 is a Medicare price rather than a Kroger one, and it is unavailable to anyone not on Part D. Ranking it as a retail cash price would show most readers the cheapest number on the site and then have them discover it was never for them.

What is the Medicare GLP-1 Bridge?

A federal programme that began on 1 July 2026, giving eligible Medicare Part D beneficiaries certain GLP-1s at $50 a month regardless of income. There are four eligibility tests and some notable exclusions — the single-dose Zepbound pen and Zepbound vials are not covered, and the $50 does not count toward your deductible or out-of-pocket limit. We set it out in full at /guides/medicare-glp1-bridge.

Does Kroger stock the oral GLP-1s?

Yes — its Bridge Program text names Wegovy tablets and Foundayo alongside the Zepbound Kwikpen, making it one of the few retail routes listing the newer oral options explicitly.

Sources

Everything on this page traces to one of the links below, retrieved on the date shown. Prices and programme terms in this market change without notice — confirm against the provider before you buy.